We are live on ! Find out more

Micro Cap Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
ATHE
76
Alterity Therapeutics
ATHE
$89.9M
$89.9M $4.96 11%
RLYB icon
77
Rallybio
RLYB
$89M
$89M $16.75 0.83%
VRCA icon
78
Verrica Pharmaceuticals
VRCA
$83.1M
$83.1M $4.84 2.02%
CING icon
79
Cingulate
CING
$82.5M
$82.5M $5.67 3.41%
ACET icon
80
Adicet Bio
ACET
$81.6M
$81.6M $8.72 3.11%
TENX icon
81
Tenax Therapeutics
TENX
$81.6M
$81.6M $2.18 6.03%
TELO icon
82
Telomir Pharmaceuticals
TELO
$81.2M
$81.2M $1.18 0%
OKYO
83
OKYO Pharma
OKYO
$80.8M
$80.8M $1.54 1.28%
GANX icon
84
Gain Therapeutics
GANX
$79.9M
$79.9M $1.83 4.19%
APLM icon
85
Apollomics
APLM
$79.6M
$79.6M $27.50 3.77%
ELTX icon
86
Elicio Therapeutics
ELTX
$78.6M
$78.6M $2.99 0.66%
CRDF icon
87
Cardiff Oncology
CRDF
$76.8M
$76.8M $0.9876 3.18%
ANVS icon
88
Annovis Bio
ANVS
$75M
$75M $1.76 3.3%
MNOV icon
89
MediciNova
MNOV
$74.3M
$74.3M $1.51 3.82%
LONA
90
LeonaBio Inc
LONA
$74.2M
$74.2M $7.88 1.62%
PLRX icon
91
Pliant Therapeutics
PLRX
$72.4M
$72.4M $1.17 1.68%
IBIO icon
92
iBio
IBIO
$71.5M
$71.5M $1.44 2.04%
SPRO icon
93
Spero Therapeutics
SPRO
$70.5M
$70.5M $1.21 1.63%
XBIT icon
94
XBiotech
XBIT
$70.4M
$70.4M $2.31 0.43%
PMVP icon
95
PMV Pharmaceuticals
PMVP
$69.5M
$69.5M $1.30 0.76%
BOLD
96
Boundless Bio
BOLD
$68.7M
$68.7M $3.02 2.72%
CSBR icon
97
Champions Oncology
CSBR
$68.6M
$68.6M $4.94 0.8%
INMB icon
98
INmune Bio
INMB
$68.6M
$68.6M $2.47 1.65%
RNXT icon
99
RenovoRx
RNXT
$68.1M
$68.1M $1.51 6.34%
RNTX
100
Rein Therapeutics
RNTX
$67.8M
$67.8M $0.7863 1.71%
2 3
4
5 6

Micro Cap Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 264 micro cap Biotechnology stocks — companies in the Biotechnology industry with a market cap under $250M — worth a combined $17.1B.

The largest by market cap are Innate Pharma (IPHA) at $247M, Minerva Neurosciences (NERV) at $245M and Veraxa Biotech AG (VRXA) at $240M.

Among institutional investors, Tenax Therapeutics (TENX) drew the most net new fund positions in Q2 2026: 45 funds opened new positions, taking total fund holders up 31 (39%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.